Elmind Capital »

Cg Oncology shares owned by Elmind Capital

Quarter-by-quarter ownership of Cg Oncology (CGON) shares owned by Elmind Capital from 13F filings

Historical chart of Elmind Capital investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by Elmind Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by Elmind Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $20M 292k 67.68

More positions owned by Elmind Capital

Cogent Biosciences (COGT)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Cytomx Therapeutics (CTMX)
Kalvista Pharmaceuticals (KALV)
Cg Oncology (CGON)
Vera Therapeutics Cl A (VERA)
Vaxcyte (PCVX)
Pharvaris N V (PHVS)
Tyra Biosciences (TYRA)
Beam Therapeutics (BEAM)
Miragen Therapeutics (VRDN)
BioCryst Pharmaceuticals (BCRX)
United Therapeutics Corporation (UTHR)
Cullinan Oncology (CGEM)

View all positions for Elmind Capital

Top funds holding Cg Oncology

Vanguard Group
Decheng Capital
Wellington Management Company
BlackRock
FMR
TCG Crossover Management
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Foresite Capital Management VI
Rtw Investments
Geode Capital Management
Franklin Resources
Bank of America Corporation
UBS Group

View all funds holding Cg Oncology